Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Opioid Prescribing Decreases When Doctors Are Monitored: Study June 7, 2016 Martha Garcia Add Your Comments Monitoring doctors who prescribe painkillers can help to reduce the rate of narcotic painkiller handed out, according to the findings of new research. In a study published in the June issue of the medical journal Health Affairs, researchers indicate that when programs monitor doctors’ prescribing habits, opioid painkiller prescriptions decrease by more than 30%. Researchers used data from a national survey to assess the effects of prescription monitoring programs in ambulatory care settings in 24 states from 2001 to 2010. The records included more than 26,000 doctor visits. The programs are used to keep track of pain prescriptions and the doctors who write them. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The study revealed prescription drug monitoring programs were associated with sustained reductions in opioid prescribing by physicians. Researchers said they were confident that state prescription drug monitoring programs are an important tool to help control the prescription opioid overdose epidemic. A report last year by the U.S. Centers for Disease Control and Prevention (CDC) also pointed to doctor’s prescribing habits as a leading cause of the worsening opioid drug overdose epidemic in the U.S. Many doctors overprescribe the strong painkillers to patients who may not need them or could benefit from other treatments, other patients “doctor shop,” receiving opioid prescriptions from multiple doctors. In another study published last year in the journal JAMA Internal Medicine, primary care doctors prescribed narcotic painkillers the most over other kinds of doctors. Prior to the start of the programs, 5.5% of office visits for pain ended with a prescription for a Schedule II opioid. Following implementation the programs, 3.7% of office visits on average resulted in a Schedule II drug prescription. Schedule II drugs are defined as drugs with a high potential for abuse and include drugs like Vicodin, methamphetamine, methadone, OxyContin, and fentanyl. Schedule I includes drugs that are not approved for medical use, but have a high potential for abuse, such as LSD and heroin. The reductions in opioid prescribing, more than 30%, were seen immediately following the launch of the programs and were maintained in the second and third years afterward. Researchers say it is possible the program itself raised awareness among doctors about controlled substance misuse and abuse and made them more cautious when prescribing narcotic painkillers. Another possibility is doctors who knew their prescribing was being monitored, were deterred from prescribing inappropriate opioid medications. The latest study gave no details on whether the drugs were appropriately prescribed. The study also did not look into whether the patient’s pain management needs were adequately met. Opioid Abuse Concerns The findings follow a recent announcement of new opioid prescription guidelines by the U.S. Centers for Disease Control and Prevention (CDC), which is designed to address the growing problem of abuse and overuse of the powerful and addictive pain medications. The CDC urges doctors to make sure patients are educated on the risks of opioid pain killers. The CDC guidelines focus on 12 principles, calling on doctors to encourage patients to use other effective treatments available, including non-opioid medications, ice, talk therapy, and exercise therapy, which has been shown to help reduce chronic low back, knee, and hip pain. The guidelines also call on doctors to let patients know what they can expect, that they will not be 100% pain free, to communicate and set realistic pain treatment goals, and to never start with the long-acting opiates, instead using the lowest possible dose. The CDC reported in December that drug overdose deaths have reached an all-time high in the U.S., increasing 137% since 2000. Overdoses involving prescription opioid painkillers, such as Vicodin and OxyContin, have reached record levels. In 2014, more than 60% of overdose deaths involved some type of narcotic painkiller. The findings also come as the FDA considers implementing mandatory doctor training before allowing doctors to prescribe narcotic pain medications. Until now, the specialized training program has been voluntary and only about half of the doctors needed to take the course have. Tags: Drug Abuse, Fentanyl, Opioid, Oxycontin, Vicodin Image Credit: | More Lawsuit Stories New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement April 3, 2025 Food Manufacturers Seek Dismissal of Ultra-Processed Food Childhood Diabetes Lawsuit April 3, 2025 Flavored Vape Restrictions Upheld by Supreme Court April 3, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: yesterday) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025) Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: 2 days ago) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 3 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
New Bard Hernia Mesh Lawsuits Continue To Be Filed Following Global Settlement (Posted: yesterday) In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery. MORE ABOUT: HERNIA MESH LAWSUITHernia Surgery Malpractice Lawsuit Cleared To Move Forward Over Botched Procedure (03/21/2025)Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (03/14/2025)Covidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: 2 days ago) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: 3 days ago) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)